Evaluating intracranial fluid dynamics provides crucial diagnostic information during high-risk pregnancy surveillance. Obstetricians frequently encounter fetal growth restriction during routine third-trimester examinations, requiring reliable neurosonographic markers to guide clinical decisions. Recent advancements in prenatal neurosonography highlight the clinical value of assessing the fetal subarachnoid space to identify subtle cerebral alterations. This prospective investigation evaluates whether standardized coronal subarachnoid measurements reliably differentiate growth-restricted fetuses from healthy, normally developing controls.

Understanding the Fetal Subarachnoid Space in Antenatal Surveillance

Accurate assessment of fetal cerebral development represents a cornerstone of contemporary obstetric practice. In physiological intrauterine development, cerebrospinal fluid circulates continuously through the cerebral ventricles and the subarachnoid compartment. Consequently, the depth of this extracerebral fluid layer reflects cortical maturation, brain volume expansion, and intracranial pressure dynamics. When placental insufficiency restricts normal fetal somatic growth, hemodynamic redistribution preferentially channels arterial perfusion toward the brain. However, persistent vascular compromise and chronic cellular hypoxemia frequently alter brain tissue microstructure and fluid distribution. Therefore, fetal medicine specialists increasingly examine extracerebral fluid spaces rather than relying solely on traditional cranial biometry. Specifically, transabdominal neurosonography allows objective evaluation of two primary coronal anatomical parameters: sinocortical width and craniocortical width. Sinocortical width measures the distance between the superior sagittal sinus and the adjacent cerebral cortex. In contrast, craniocortical width quantifies the space between the calvarium and the cortical surface. Because these anatomical landmarks directly reflect extracerebral fluid volume, they offer sensitive barometers of altered neurodevelopment.

Study Design and Standardized Coronal Neurosonography

To rigorously evaluate extracerebral fluid alterations, researchers designed a prospective, cross-sectional comparative study across specialized maternal-fetal medicine clinics. The investigation evaluated 281 singleton pregnancies between 28 + 0 and 36 + 6 weeks of gestation. Specifically, the cohort enrolled 145 fetuses diagnosed with fetal growth restriction and 136 appropriate-for-gestational-age controls. Two experienced sonographers independently performed transabdominal ultrasound examinations using high-resolution transducers to measure sinocortical and craniocortical widths. Furthermore, the standardized imaging protocol mandated obtaining a coronal plane at the level of the foramen of Monro and frontal horns. This orientation ensured clear visualization of the calvarium, superior sagittal sinus, interhemispheric fissure, and cerebral mantle. Additionally, the investigators utilized gestational-age-adjusted linear regression models with Holm correction to eliminate confounding effects. They also conducted sensitivity analyses adjusting for head circumference to verify whether fluid differences depended on cranial size. Consequently, the study established a rigorous methodological framework with high reproducibility across both sonographic observers.

Key Findings: Sinocortical and Craniocortical Narrowing in FGR

The quantitative results revealed marked differences in extracerebral fluid compartments between the two study groups. Most notably, fetuses with growth restriction demonstrated a mean sinocortical width of 2.26 ± 0.86 mm, compared to 2.68 ± 0.96 mm in appropriate-for-gestational-age controls. Linear regression analysis adjusted for gestational age revealed a statistically significant mean adjusted difference of -0.426 mm. Furthermore, the Holm-adjusted p-value remained highly significant, confirming that this fluid reduction did not occur by random chance. In addition, craniocortical width showed corresponding significant narrowing in the growth-restricted cohort. Sensitivity analyses controlling for head circumference confirmed that this reduction persisted regardless of overall cranial dimensions. Therefore, smaller skull size alone cannot account for the compressed fluid spaces observed in growth-restricted fetuses. Interobserver reliability assessments yielded excellent intraclass correlation coefficients, proving that independent sonographers achieve consistent measurements. As a result, these robust findings provide reliable normative benchmarks for clinicians evaluating intracranial fluid spaces during late pregnancy.

Pathophysiological Mechanisms Behind Extracerebral Fluid Loss

Understanding why growth-restricted fetuses develop narrowed subarachnoid spaces requires an analysis of cerebral hemodynamics and tissue adaptations. When placental vascular resistance increases, fetal autoregulatory mechanisms lower cerebral vascular resistance to maintain vital oxygen delivery. However, sustained hypoxemia and nutrient deprivation impair blood-brain barrier integrity and cellular metabolism. Consequently, cytotoxic edema or astrocytic swelling may expand the brain parenchyma, thereby effacing the overlying subarachnoid spaces. In addition, chronic hemodynamic redistribution alters the balance between intracranial arterial perfusion, venous pressure, and cerebrospinal fluid production. Some investigators suggest that decreased cerebrospinal fluid secretion at the choroid plexus contributes directly to diminished sinocortical dimensions. Moreover, delayed cortical maturation and altered sulcation in growth-restricted fetuses modify the physical relationship between the calvarium and the brain. Therefore, the observed reduction in subarachnoid dimensions reflects complex pathophysiological adaptations rather than simple biometric scaling. Thus, measuring these fluid compartments provides clinicians with direct insights into fetal neurovascular status.

Clinical Implications for Risk Stratification and Practice

Incorporating standardized coronal subarachnoid measurements into routine ultrasound examinations offers practical advantages for obstetricians and radiologists. Clinicians currently rely primarily on Doppler evaluations of the umbilical artery and middle cerebral artery to guide management. However, Doppler measurements assess vascular resistance patterns rather than direct brain parenchymal adaptations. Consequently, evaluating coronal sinocortical width provides a complementary structural biomarker of altered fluid dynamics. Clinicians can easily obtain this coronal view during standard third-trimester neurosonographic scans without expensive specialized software. Furthermore, identifying marked subarachnoid effacement helps clinicians detect fetuses experiencing advanced hemodynamic compromise. Additionally, this anatomical assessment helps distinguish pathologically growth-restricted fetuses from constitutionally small fetuses whose intracranial fluid spaces remain normal. As a result, prenatal teams can optimize monitoring intervals, plan delivery timing more effectively, and coordinate neonatal neurodevelopmental surveillance. Therefore, coronal subarachnoid assessment serves as an accessible, highly impactful tool for antenatal risk stratification.

Frequently Asked Questions

How does sinocortical width differ from craniocortical width on fetal ultrasound?

Sinocortical width measures the shortest distance between the lateral edge of the superior sagittal sinus and the outermost surface of the adjacent cerebral cortex. In contrast, craniocortical width quantifies the perpendicular distance from the inner bone surface of the calvarium to the underlying cerebral cortex. Both parameters evaluate extracerebral cerebrospinal fluid volume in a standardized coronal plane, providing complementary diagnostic markers for identifying intracranial fluid redistribution in compromised fetuses.

Why is subarachnoid space narrowing significant in fetal growth restriction?

Subarachnoid space narrowing in fetal growth restriction reflects underlying physiological adaptations to chronic placental insufficiency. When persistent hypoxia triggers cerebral vascular redistribution, brain tissue may develop subtle cytotoxic cellular swelling. Additionally, altered cerebrospinal fluid production at the choroid plexus reduces fluid depth around the cerebral hemispheres. Consequently, compressed fluid spaces indicate altered cerebral fluid dynamics and parenchymal volume changes that extend beyond simple biometric head circumference variations in growth-restricted fetuses.

Can sonographers reliably measure the coronal subarachnoid space in routine practice?

Yes, trained sonographers can achieve high interobserver reproducibility using standardized transabdominal neurosonography protocols. Imaging specialists obtain a clear coronal view at the level of the foramen of Monro and frontal horns using standard ultrasound equipment. By maintaining consistent caliper placement perpendicular to the cranial cortex and avoiding excessive abdominal probe pressure, operators reliably record sinocortical and craniocortical dimensions, facilitating dependable comparative assessments across different clinical settings and serial evaluations.

Disclaimer: This content is for informational and educational purposes only and should not be taken as professional medical advice. Always consult a healthcare provider for medical concerns. Refer to the latest local and national guidelines for clinical practice.

References

1. Selvi E et al. Coronal Subarachnoid-Space Measurements in Fetuses with Growth Restriction and Appropriate-for-Gestational-Age Controls: A Prospective Comparative Study. J Ultrasound Med. 2026 Sep 21. doi: 10.1002/jum.70486. PMID: 42765281.
2. Wandel A, Weissbach T, Katorza E, Ziv-Baran T. Subarachnoid Space Measurements in Apparently Healthy Fetuses Using MR Imaging. AJNR Am J Neuroradiol. 2023;44(6):708-714. doi: 10.3174/ajnr.A7864.
3. Onn-Margalit L, Weissbach T, Katorza E. An Association Between Fetal Subarachnoid Space and Various Pathologies Using MR Imaging. J Clin Med. 2024;13(22):6842. doi: 10.3390/jcm13226842.